Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biochemical basis for evaluating oral contraceptives

M H Briggs

    Australian Family Physician
    |February 1, 1980
    PubMed
    Summary

    Estrogens boost HDL cholesterol, while progestogens lower it. Comparing biochemical effects of oral contraceptives can help assess cardiovascular risk.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Systems for collaboration. Integrating multiple perspectives.

    Child and adolescent psychiatric clinics of North America·1999
    Same author

    Development of a monoclonal antibody for use in radioimmunoassay of ethynylestradiol.

    Steroids·1986
    Same author

    Multielement determination in biological materials by differential pulse voltammetry.

    Analytical chemistry·1985
    Same author

    Determination of homocysteine in urine.

    Journal of chromatography·1985
    Same author

    Reversed-phase high-performance liquid chromatography for the determination of steroid hormones in oral contraceptives.

    Journal of chromatography·1984
    Same author

    Changes in urinary homocysteine following synthetic steroidal estrogen and progestogen administration to rats.

    Steroids·1984

    Area of Science:

    • Endocrinology
    • Cardiovascular Science
    • Pharmacology

    Background:

    • Oral contraceptives (OCs) contain estrogens and progestogens.
    • These hormones have known effects on lipid metabolism and cardiovascular markers.
    • Variability exists in the biochemical profiles of different OC formulations.

    Purpose of the Study:

    • To analyze the differential effects of estrogens and progestogens in OCs on key biochemical markers.
    • To explore the relationship between these biochemical changes and cardiovascular risk.
    • To provide a basis for selecting OCs with a favorable cardiovascular risk profile.

    Main Methods:

    • Comparative analysis of biochemical data related to OCs.
    • Focus on high-density lipoprotein (HDL) cholesterol levels.
    • Examination of effects on blood coagulation factors and the renin-angiotensin-aldosterone system.

    Main Results:

    • Estrogens were found to stimulate and increase HDL cholesterol.
    • Progestogens demonstrated a decreasing effect on HDL cholesterol.
    • Significant variations in HDL impact were observed across different estrogen-progestogen combinations.
    • Similar differential effects were noted for coagulation factors and the renin-angiotensin-aldosterone axis.

    Conclusions:

    • The biochemical effects of OCs on HDL cholesterol, coagulation, and the renin-angiotensin-aldosterone axis vary significantly.
    • Comparative biochemical data can inform the selection of OCs to mitigate cardiovascular risk.
    • Tailoring OC choice based on biochemical profiles may optimize patient safety.

    Related Experiment Videos